Wafaa El-Sadr

Q: What Schools Are Affiliated With Wafaa El-Sadr

Wafaa El-Sadr is affiliated with the following schools: Cairo University, Columbia University

Wafaa El-Sadr's AcademicInfluence.com Rankings

Wafaa El-Sadr

Medical

#603

World Rank

#808

Historical Rank

Public Health

#102

World Rank

#108

Historical Rank

Epidemiology

#344

World Rank

#362

Historical Rank

medical Degrees

Wafaa El-Sadr

Philosophy

#5581

World Rank

#8422

Historical Rank

Logic

#4372

World Rank

#5655

Historical Rank

philosophy Degrees

Download Badge

Medical
Philosophy

Wafaa El-Sadr's Degrees

Doctorate Medicine Cairo University
Masters Public Health Columbia University

Why Is Wafaa El-Sadr Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Wafaa El-Sadr is a Columbia University Professor and the director of ICAP at Columbia University, Columbia World Projects and the Center for Infectious Disease Epidemiologic Research at Columbia Mailman School of Public Health.

(See a Problem?)

Wafaa El-Sadr's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

CD4+ count-guided interruption of antiretroviral treatment. (2006) (1832)
Combination antiretroviral therapy and the risk of myocardial infarction. (2003) (1456)
Class of antiretroviral drugs and the risk of myocardial infarction. (2007) (1220)
Liver-related deaths in persons infected with the human immunodeficiency virus: the D:A:D study. (2006) (1217)
Cardiovascular disease risk factors in HIV patients – association with antiretroviral therapy. Results from the DAD study (2003) (1087)
Use of nucleoside reverse transcriptase inhibitors and risk of myocardial infarction in HIV-infected patients enrolled in the D:A:D study: a multi-cohort collaboration (2008) (897)
Timing of initiation of antiretroviral drugs during tuberculosis therapy. (2010) (728)
Microfluidics-based diagnostics of infectious diseases in the developing world (2011) (691)
Risk of myocardial infarction in patients with HIV infection exposed to specific individual antiretroviral drugs from the 3 major drug classes: the data collection on adverse events of anti-HIV drugs (D:A:D) study. (2010) (645)
Integration of antiretroviral therapy with tuberculosis treatment. (2011) (518)
Guidelines for preventing opportunistic infections among HIV-infected persons - 2002 (2002) (474)
Factors associated with specific causes of death amongst HIV-positive individuals in the D:A:D study (2010) (450)
Incidence and Risk Factors for New-Onset Diabetes in HIV-Infected Patients (2008) (433)
Lipid profiles in HIV-infected patients receiving combination antiretroviral therapy: are different antiretroviral drugs associated with different lipid profiles? (2004) (352)
Predicting the risk of cardiovascular disease in HIV-infected patients: the Data collection on Adverse Effects of Anti-HIV Drugs Study (2010) (348)
The use of the Framingham equation to predict myocardial infarctions in HIV‐infected patients: comparison with observed events in the D:A:D Study (2006) (319)
Effects of HIV disease on lipid, glucose and insulin levels: results from a large antiretroviral‐naïve cohort (2005) (286)
Variation of chest radiographic patterns in pulmonary tuberculosis by degree of human immunodeficiency virus-related immunosuppression. The Terry Beirn Community Programs for Clinical Research on AIDS (CPCRA). The AIDS Clinical Trials Group (ACTG). (1997) (269)
Risk factors for infection with human immunodeficiency virus among intravenous drug abusers in New York City. (1987) (259)
Cardio- and cerebrovascular events in HIV-infected persons (2004) (257)
Modelling the 3‐year risk of myocardial infarction among participants in the Data Collection on Adverse Events of Anti‐HIV Drugs (DAD) study (2003) (246)
Impact of Antiretroviral Therapy on Incidence of Pregnancy among HIV-Infected Women in Sub-Saharan Africa: A Cohort Study (2010) (227)
Inferior clinical outcome of the CD4+ cell count-guided antiretroviral treatment interruption strategy in the SMART study: role of CD4+ Cell counts and HIV RNA levels during follow-up. (2008) (212)
Safety and tolerability of tenofovir vaginal gel in abstinent and sexually active HIV-infected and uninfected women (2006) (189)
Effect of Universal Testing and Treatment on HIV Incidence - HPTN 071 (PopART). (2019) (185)
Streptococcus pneumoniae infections and bacteremia in patients with acquired immune deficiency syndrome, with report of a pneumococcal vaccine failure. (1984) (183)
Psychopathology in male and female intravenous drug users with and without HIV infection. (1994) (183)
Why reinvent the wheel? Leveraging the lessons of HIV scale-up to confront non-communicable diseases (2011) (180)
Africa in the Path of Covid-19. (2020) (175)
Multidrug-resistant tuberculosis in patients without HIV infection. (1995) (170)
Rates of cardiovascular disease following smoking cessation in patients with HIV infection: results from the D:A:D study * (2010) (170)
Antiretroviral Treatment and Prevention of Peripartum and Postnatal HIV Transmission in West Africa: Evaluation of a Two-Tiered Approach (2007) (169)
AIDS in America--forgotten but not gone. (2010) (166)
Atovaquone compared with dapsone for the prevention of Pneumocystis carinii pneumonia in patients with HIV infection who cannot tolerate trimethoprim, sulfonamides, or both. Community Program for Clinical Research on AIDS and the AIDS Clinical Trials Group. (1998) (166)
Acquired rifamycin resistance with twice-weekly treatment of HIV-related tuberculosis. (2006) (159)
Comparison of 2 doses of liposomal amphotericin B and conventional amphotericin B deoxycholate for treatment of AIDS-associated acute cryptococcal meningitis: a randomized, double-blind clinical trial of efficacy and safety. (2010) (151)
The challenge of minority recruitment in clinical trials for AIDS. (1992) (151)
A controlled trial of isoniazid in persons with anergy and human immunodeficiency virus infection who are at high risk for tuberculosis. Terry Beirn Community Programs for Clinical Research on AIDS. (1997) (145)
Risk for opportunistic disease and death after reinitiating continuous antiretroviral therapy in patients with HIV previously receiving episodic therapy: a randomized trial. (2008) (144)
Discontinuation of prophylaxis against Mycobacterium avium complex disease in HIV-infected patients who have a response to antiretroviral therapy. Terry Beirn Community Programs for Clinical Research on AIDS. (2000) (140)
Evaluation of an intensive intermittent-induction regimen and duration of short-course treatment for human immunodeficiency virus-related pulmonary tuberculosis. Terry Beirn Community Programs for Clinical Research on AIDS (CPCRA) and the AIDS Clinical Trials Group (ACTG). (1998) (136)
Cardiovascular disease and use of contemporary protease inhibitors: the D:A:D international prospective multicohort study. (2018) (136)
Weekly Fluconazole for the Prevention of Mucosal Candidiasis in Women with HIV Infection (1997) (133)
Frequency, severity and duration of immune reconstitution events in HIV-related tuberculosis. (2007) (130)
Predictors of Hypertension and Changes of Blood Pressure in HIV-Infected Patients (2005) (130)
The HIV care continuum: no partial credit given. (2012) (127)
USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus: disease-specific recommendations. USPHS/IDSA Prevention of Opportunistic Infections Working Group. (1995) (120)
Survival and prognostic factors in severe Pneumocystis carinii pneumonia requiring mechanical ventilation. (1988) (117)
Development of AIDS, HIV seroconversion, and potential co-factors for T4 cell loss in a cohort of intravenous drug users. (1987) (117)
Sensitivity Analysis and Potential Uses of a Novel Gamma Interferon Release Assay for Diagnosis of Tuberculosis (2006) (115)
The AIDS epidemic among blacks and Hispanics. (1987) (115)
Body Composition and Metabolic Changes in Antiretroviral-Naive Patients Randomized to Didanosine and Stavudine vs. Abacavir and Lamivudine (2005) (114)
Unrecognized human immunodeficiency virus infection in the elderly. (1995) (114)
Diabetes Mellitus, Preexisting Coronary Heart Disease, and the Risk of Subsequent Coronary Heart Disease Events in Patients Infected With Human Immunodeficiency Virus: The Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D Study) (2009) (112)
Integration of tuberculosis and HIV services in sub-Saharan Africa: lessons learned. (2010) (110)
Outcome of HIV infected children with culture confirmed tuberculosis (2005) (109)
The Immune Reconstitution Inflammatory Syndrome After Antiretroviral Therapy Initiation in Patients With Tuberculosis: Findings From the SAPiT Trial (2012) (108)
The Problem of Late ART Initiation in Sub-Saharan Africa: A Transient Aspect of Scale-up or a Long-term Phenomenon? (2013) (104)
A universal testing and treatment intervention to improve HIV control: One-year results from intervention communities in Zambia in the HPTN 071 (PopART) cluster-randomised trial (2017) (104)
Atazanavir is not associated with an increased risk of cardio or cerebrovascular disease events (2013) (103)
Advanced HIV disease at entry into HIV care and initiation of antiretroviral therapy during 2006-2011: findings from four sub-saharan African countries. (2014) (102)
Is there continued evidence for an association between abacavir usage and myocardial infarction risk in individuals with HIV? A cohort collaboration (2016) (102)
A review of efficacy studies of 6-month short-course therapy for tuberculosis among patients infected with human immunodeficiency virus: differences in study outcomes. (2001) (102)
Individual and household level factors associated with malaria incidence in a highland region of Ethiopia: a multilevel analysis. (2009) (101)
Effect of combined therapy with ansamycin, clofazimine, ethambutol, and isoniazid for Mycobacterium avium infection in patients with AIDS. (1989) (100)
Financial Incentives for Linkage to Care and Viral Suppression Among HIV-Positive Patients (2017) (100)
Long-Term Body Composition and Metabolic Changes in Antiretroviral Naive Persons Randomized to Protease Inhibitor-, Nonnucleoside Reverse Transcriptase Inhibitor-, or Protease Inhibitor Plus Nonnucleoside Reverse Transcriptase Inhibitor-Based Strategy (2007) (99)
High prevalence of the metabolic syndrome in HIV-infected patients: impact of different definitions of the metabolic syndrome (2010) (97)
The safety and efficacy of adefovir dipivoxil in patients with advanced HIV disease: a randomized, placebo-controlled trial (2001) (93)
Scale-up of HIV Treatment Through PEPFAR: A Historic Public Health Achievement (2012) (92)
HIV Acquisition Among Women From Selected Areas of the United States (2013) (90)
Challenges of a Hidden Epidemic: HIV Prevention Among Women in the United States (2010) (90)
ULTRASTRUCTURAL MARKERS OF AIDS (1983) (90)
Rapid HIV self-testing: long in coming but opportunities beckon. (2013) (89)
Focus on Women: Linking HIV Care and Treatment with Reproductive Health Services in the MTCT-Plus Initiative (2005) (88)
Results of a tuberculosis-specific IFN-gamma assay in children at high risk for tuberculosis infection. (2006) (87)
Cardiovascular risk factors associated with lower baseline cognitive performance in HIV-positive persons (2010) (87)
IAPAC Guidelines for Optimizing the HIV Care Continuum for Adults and Adolescents (2015) (87)
A randomized trial of daily and thrice-weekly trimethoprim-sulfamethoxazole for the prevention of Pneumocystis carinii pneumonia in human immunodeficiency virus-infected persons. Terry Beirn Community Programs for Clinical Research on AIDS (CPCRA) (1999) (87)
Correlation of bronchoalveolar lavage cell populations with clinical severity of Pneumocystis carinii pneumonia. (1988) (87)
Quantitation of β2-Microglobulin and Other Immune Characteristics in a Prospective Study of Men at Risk for Acquired Immune Deficiency Syndrome (1984) (86)
Prevention of mother-to-child transmission services as a gateway to family-based human immunodeficiency virus care and treatment in resource-limited settings: rationale and international experiences. (2007) (86)
Oral manifestations of HIV infection in homosexual men and intravenous drug users. Study design and relationship of epidemiologic, clinical, and immunologic parameters to oral lesions. (1994) (85)
Mobile device for disease diagnosis and data tracking in resource-limited settings. (2013) (85)
Acceptability of tenofovir gel as a vaginal microbicide among women in a phase I trial: a mixed-methods study. (2008) (85)
Scale-up of HIV care and treatment: can it transform healthcare services in resource-limited settings? (2007) (85)
Safety and acceptability of cellulose sulfate as a vaginal microbicide in HIV-infected women (2006) (84)
Implementing family‐focused HIV care and treatment: the first 2 years’ experience of the mother‐to‐child transmission ‐plus program in Abidjan, Côte d’Ivoire (2009) (83)
A paradigm shift: focus on the HIV prevention continuum. (2014) (83)
Predicting the short-term risk of diabetes in HIV-positive patients: the Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) study (2012) (82)
The impact of human immunodeficiency virus infection on drug-resistant tuberculosis. (1996) (81)
A Pilot Study of Once-Daily Antiretroviral Therapy Integrated With Tuberculosis Directly Observed Therapy in a Resource-Limited Setting (2004) (81)
When to start ART in Africa--an urgent research priority. (2013) (79)
‘Men usually say that HIV testing is for women’: gender dynamics and perceptions of HIV testing in Lesotho (2014) (78)
Achieving the fourth 90: healthy aging for people living with HIV (2018) (78)
Program-level and contextual-level determinants of low-median CD4+ cell count in cohorts of persons initiating ART in eight sub-Saharan African countries (2011) (77)
Gender and Care: Access to HIV Testing, Care, and Treatment (2009) (77)
Short-term acceptability of the female condom among staff and patients at a New York City Hospital. (1995) (75)
Limited awareness of pre-exposure prophylaxis among black men who have sex with men and transgender women in New York city (2018) (74)
HIV, aging and continuity care: strengthening health systems to support services for noncommunicable diseases in low-income countries (2012) (73)
The acquired immunodeficiency syndrome: an ultrastructural study. (1985) (73)
Predictors of advanced chronic kidney disease and end-stage renal disease in HIV-positive persons (2014) (72)
Association of Adherence Support and Outreach Services with Total Attrition, Loss to Follow-Up, and Death among ART Patients in Sub-Saharan Africa (2012) (72)
Changes over time in risk factors for cardiovascular disease and use of lipid-lowering drugs in HIV-infected individuals and impact on myocardial infarction. (2008) (71)
Strengthening Health Systems for Chronic Care: Leveraging HIV Programs to Support Diabetes Services in Ethiopia and Swaziland (2012) (71)
Swaziland HIV Incidence Measurement Survey (SHIMS): a prospective national cohort study. (2017) (71)
Factors Associated with Late Antiretroviral Therapy Initiation among Adults in Mozambique (2012) (70)
HIV-associated tuberculosis: diagnostic and treatment challenges. (2008) (70)
A Prospective Randomized Trial of Four Three-Drug Regimens in the Treatment of Disseminated Mycobacterium avium Complex Disease in AIDS Patients: Excess Mortality Associated with High-Dose Clarithromycin (1999) (69)
Nevirapine‐associated toxicity in HIV‐infected Thai men and women, including pregnant women (2007) (64)
HIV, Tuberculosis, and Noncommunicable Diseases: What Is Known About the Costs, Effects, and Cost-effectiveness of Integrated Care? (2014) (62)
Antiretroviral therapy for the prevention of HIV transmission: what will it take? (2014) (61)
Effectiveness of a combination strategy for linkage and retention in adult HIV care in Swaziland: The Link4Health cluster randomized trial (2017) (59)
Community health worker perspectives on a new primary health care initiative in the Eastern Cape of South Africa (2017) (59)
Associations between immune depression and cardiovascular events in HIV infection (2013) (58)
The Impact of HIV Scale-Up on Health Systems: A Priority Research Agenda (2009) (57)
Host country responses to non-communicable diseases amongst Syrian refugees: a review (2019) (57)
Intravenous drug use and the heterosexual transmission of the human immunodeficiency virus. Current trends in New York City. (1987) (56)
Streptococcus bovis bacteremia and meningitis associated with Strongyloides stercoralis colitis in a patient infected with human immunodeficiency virus. (1994) (56)
Serum IgD elevation is an early marker of B cell activation during infection with the human immunodeficiency viruses. (1987) (56)
Impact of a universal testing and treatment intervention on HIV incidence in Zambia and South Africa: results of the HPTN 071 (PopART) community-randomized trial (2019) (56)
Use of antiretroviral therapy and risk of end-stage liver disease and hepatocellular carcinoma in HIV-positive persons (2016) (54)
Integrating tuberculosis and HIV care in rural Rwanda. (2008) (54)
Interruption of antiretroviral therapy is associated with increased plasma cystatin C (2009) (54)
HIV Population Surveys - Bringing Precision to the Global Response. (2018) (53)
The Nursing Education Partnership Initiative (NEPI): innovations in nursing and midwifery education. (2014) (53)
Elevated triglycerides and risk of myocardial infarction in HIV-positive persons (2011) (52)
Addressing research priorities for prevention of HIV infection in the United States. (2010) (52)
Pregnant and breastfeeding women: A priority population for HIV viral load monitoring (2017) (52)
Antiretroviral treatment in resource-poor settings: clinical research priorities (2002) (52)
Increased risk of cardiovascular disease (CVD) with age in HIV‐positive men: a comparison of the D:A:D CVD risk equation and general population CVD risk equations (2014) (51)
The President's Emergency Plan for AIDS Relief--is the emergency over? (2008) (51)
Where are the positives? HIV testing in sub-Saharan Africa in the era of test and treat. (2019) (50)
Implementing antiretroviral therapy in resource-constrained settings: opportunities and challenges in integrating HIV and tuberculosis care (2004) (50)
Determination of the Underlying Cause of Death in Three Multicenter International HIV Clinical Trials (2008) (50)
Susceptibility to levofloxacin of Mycobacterium tuberculosis isolates from patients with HIV‐related tuberculosis and characterization of a strain with levofloxacin monoresistance (1997) (49)
CD4+ Cell Count Testing More Effective Than HIV Disease Clinical Staging in Identifying Pregnant and Postpartum Women Eligible for Antiretroviral Therapy in Resource-Limited Settings (2010) (48)
Performance of symptom-based tuberculosis screening among people living with HIV: not as great as hoped (2014) (48)
Directly observed therapy for tuberculosis: the Harlem Hospital experience, 1993. (1996) (48)
Neurologic and neuropsychological manifestations of human immunodeficiency virus infection in intravenous drug users without acquired immunodeficiency syndrome. Relationship to head injury. (1992) (48)
Pentamidine-associated fatal acute pancreatitis. (1986) (47)
A temporal-spatial analysis of malaria transmission in Adama, Ethiopia. (2009) (47)
Predictors of latent tuberculosis infection treatment completion in the United States: an inner city experience. (2010) (47)
PEPFAR, Health System Strengthening, and Promoting Sustainability and Country Ownership (2012) (46)
Preventing HIV Infection in Women (2013) (46)
The epidemic of acquired immunodeficiency syndrome (AIDS) and suggestions for its control in drug abusers. (1984) (45)
Presence of the Metabolic Syndrome Is Not a Better Predictor of Cardiovascular Disease Than the Sum of Its Components in HIV-Infected Individuals (2009) (45)
Prevalence and antimicrobial patterns of Acinetobacter baumannii on hands and nares of hospital personnel and patients: the iceberg phenomenon again. (2002) (45)
Factors associated with initiation of antiretroviral therapy in the advanced stages of HIV infection in six Ethiopian HIV clinics, 2012 to 2013 (2016) (45)
Game Changers: Why Did the Scale-Up of HIV Treatment Work Despite Weak Health Systems? (2011) (44)
Antiretroviral Therapy for Prevention Is a Combination Strategy (2013) (44)
How Can the Health System Retain Women in HIV Treatment for a Lifetime? A Discrete Choice Experiment in Ethiopia and Mozambique (2016) (44)
Modeling the impact on the HIV epidemic of treating discordant couples with antiretrovirals to prevent transmission (2011) (43)
Four-year prospective study of homosexual men: correlation of immunologic abnormalities, clinical status, and serology to human immunodeficiency virus. (1987) (42)
Sex differences in the associations of HIV disease characteristics and body composition in antiretroviral-naive persons. (2005) (41)
Predictors for multidrug-resistant tuberculosis among HIV-infected patients and response to specific drug regimens. Terry Beirn Community Programs for Clinical Research on AIDS (CPCRA) and the AIDS Clinical Trials Group (ACTG), National Institutes for Health. (1999) (41)
HBV or HCV Coinfections and Risk of Myocardial Infarction in HIV-Infected Individuals: The D:A:D Cohort Study (2010) (41)
Retention strategies and factors associated with missed visits among low income women at increased risk of HIV acquisition in the US (HPTN 064). (2014) (40)
Acceptability of tenofovir gel as a vaginal microbicide by US male participants in a Phase I clinical trial (HPTN 050) (2007) (40)
Reproductive decisions in HIV-infected individuals (2005) (40)
Utility of tuberculosis directly observed therapy programs as sites for access to and provision of antiretroviral therapy in resource-limited countries. (2004) (39)
Tuberculosis Knowledge, Attitudes, and Beliefs in Foreign-born and US-born Patients with Latent Tuberculosis Infection (2010) (39)
Transgender People and HIV Prevention: What We Know and What We Need to Know, a Call to Action (2016) (39)
Availability of nutritional support services in HIV care and treatment sites in sub-Saharan African countries (2011) (39)
Consensus statement on the role of health systems in advancing the long-term well-being of people living with HIV (2021) (39)
Characteristics and Outcomes among Older HIV-Positive Adults Enrolled in HIV Programs in Four Sub-Saharan African Countries (2014) (39)
Asymptomatic myocardial ischaemia in HIV-infected adults (2008) (37)
A prospective randomized trial of four three-drug regimens in the treatment of disseminated Mycobacterium avium complex disease in AIDS patients: excess mortality associated with high-dose clarithromycin. Terry Beirn Community Programs for Clinical Research on AIDS. (1999) (37)
Patients Enrolled in HIV Care in Mozambique: Baseline Characteristics and Follow-Up Outcomes (2011) (37)
Risk of Myocardial Infaction with Exposure to Specific ARV from the PI, NNRTI, And NRTI Drug Classes: The D:A:D Study (2009) (37)
Disease Control Priorities, Third Edition (Volume 6): Major Infectious Diseases (2017) (36)
Use of a Comprehensive HIV Care Cascade for Evaluating HIV Program Performance: Findings From 4 Sub-Saharan African Countries (2015) (36)
Building on the HIV chronic care platform to address noncommunicable diseases in sub-Saharan Africa: a research agenda (2018) (35)
Oral candidiasis in HIV infection: predictive value and comparison of findings in injecting drug users and homosexual men. (1997) (34)
HIV and people who use drugs in central Asia: confronting the perfect storm. (2013) (34)
Hormonal contraception and HIV disease progression: a multicountry cohort analysis of the MTCT-Plus Initiative (2009) (34)
Evaluation of HIV protease inhibitor use and the risk of sudden death or nonhemorrhagic stroke. (2012) (32)
PEPFAR programs linked to more deliveries in health facilities by African women who are not infected with HIV. (2012) (32)
Reaching global HIV/AIDS goals: What got us here, won't get us there (2017) (32)
Initiation of antiretroviral therapy among pregnant women in resource-limited countries: CD4+ cell count response and program retention (2010) (31)
Building on the HIV platform: tackling the challenge of noncommunicable diseases among persons living with HIV. (2018) (31)
Anxiety and depressive symptoms are associated with poor sleep health during a period of COVID-19-induced nationwide lockdown: a cross-sectional analysis of adults in Jordan (2020) (31)
Characteristics of Multiple and Concurrent Partnerships Among Women At High Risk for HIV Infection (2014) (30)
Recommendations for prophylaxis against Pneumocystis carinii pneumonia for persons infected with human immunodeficiency virus. U.S. Public Health Service Task Force on Antipneumocystis Prophylaxis in Patients with Human Immunodeficiency Virus Infection. (1993) (30)
Tuberculosis and HIV–Needed: A New Paradigm for the Control and Management of Linked Epidemics (2007) (30)
Lack of association between use of efavirenz and death from suicide: evidence from the D:A:D study (2014) (30)
Exposure to PI and NNRTI and risk of myocardial infarction: results from the D:A:D study group (2006) (28)
Association between exposure to antiretroviral drugs and the incidence of hypertension in HIV‐positive persons: the Data Collection on Adverse Events of Anti‐HIV Drugs (D:A:D) study (2018) (28)
Clinician Practices and Attitudes Regarding Early Antiretroviral Therapy in the United States (2012) (28)
Risk of human immunodeficiency virus type 1-related neurologic disease in a cohort of intravenous drug users. (1995) (28)
Body Mass Index and the Risk of Serious Non-AIDS Events and All-Cause Mortality in Treated HIV-Positive Individuals: D A D Cohort Analysis (2018) (28)
Antiretroviral Therapy: A Promising HIV Prevention Strategy? (2010) (27)
Sexual Behaviors of US Women at Risk of HIV Acquisition: A Longitudinal Analysis of Findings from HPTN 064 (2015) (27)
Missed Opportunities to Address Cardiovascular Disease Risk Factors amongst Adults Attending an Urban HIV Clinic in South Africa (2015) (27)
Identifying Perceived Barriers along the HIV Care Continuum (2016) (26)
High-dose corticosteroids as adjunct therapy in severe Pneumocystis carinii pneumonia. (1986) (26)
Visceral and Subcutaneous Adiposity Measurements in Adults: Influence of Measurement Site (2007) (26)
In vitro immune mechanisms associated with clearance of microfilariae of Dirofilaria immitis. (1983) (26)
Population health and individualized care in the global AIDS response: synergy or conflict? (2016) (25)
Selecting a viral load threshold for routine monitoring in resource‐limited settings: optimizing individual health and population impact (2017) (25)
Letting HIV transform academia--embracing implementation science. (2014) (25)
Sexual functioning in HIV+ and HIV- injected drug-using women. (1993) (24)
US withdrawal from WHO is unlawful and threatens global and US health and security (2020) (24)
“It Makes You Feel Like Someone Cares” acceptability of a financial incentive intervention for HIV viral suppression in the HPTN 065 (TLC-Plus) study (2017) (24)
Integrating HIV services and other health services: A systematic review and meta-analysis (2021) (24)
Realizing the potential of routine viral load testing in sub‐Saharan Africa (2017) (24)
COVID-19 testing, case, and death rates and spatial socio-demographics in New York City: An ecological analysis as of June 2020 (2021) (24)
Response Rates of Medical Providers to Internet Surveys Regarding Their Adoption of Preexposure Prophylaxis for HIV: Methodological Implications (2018) (24)
Exposure to Haart is associated with and increased risk of myocardial infarction: the D:A:D study (2003) (24)
Understanding low sensitivity of community-based HIV rapid testing: experiences from the HPTN 071 (PopART) trial in Zambia and South Africa (2017) (24)
Cessation of Cigarette Smoking and the Impact on Cancer Incidence in Human Immunodeficiency Virus–infected Persons: The Data Collection on Adverse Events of Anti-HIV Drugs Study (2018) (23)
The effect of methadone on immunological parameters among HIV-positive and HIV-negative drug users. (1994) (23)
Can a peer-based intervention impact adherence to the treatment of latent tuberculous infection? (2013) (22)
Addressing chronic diseases in protracted emergencies: Lessons from HIV for a new health imperative (2018) (22)
Integrating HIV care and HIV prevention: legal, policy and programmatic recommendations. (2008) (22)
Design of the HPTN 065 (TLC-Plus) study: A study to evaluate the feasibility of an enhanced test, link-to-care, plus treat approach for HIV prevention in the United States (2017) (22)
Mother and child both matter: reconceptualizing the prevention of mother-to-child transmission care continuum (2015) (22)
Sexually Transmitted Infections in Women Infected With the Human Immunodeficiency Virus (1998) (22)
Reporting and Evaluation of HIV-Related Clinical Endpoints in Two Multicenter International Clinical Trials (2006) (22)
China’s health assistance to Africa: opportunism or altruism? (2016) (21)
Morbidity and mortality from COVID-19 post-vaccination breakthrough infections in association with vaccines and the emergence of variants in Bahrain (2021) (21)
AIDS in America - Back in the Headlines at Long Last. (2019) (21)
Corticosteroids as adjunctive therapy for Pneumocystis pneumonia in patients with AIDS. (1991) (21)
Venue-based recruitment of women at elevated risk for HIV: an HIV Prevention Trials Network study. (2014) (21)
Rates of tuberculosis infection in healthcare workers providing services to HIV-infected populations. Terry Beirn Community Programs for Clinical Research on AIDS. (1998) (21)
The accurate diagnosis of oral lesions in human immunodeficiency virus infection. Impact on medical staging. (1996) (20)
The Link4Health study to evaluate the effectiveness of a combination intervention strategy for linkage to and retention in HIV care in Swaziland: protocol for a cluster randomized trial (2015) (20)
Integrating cardiovascular disease risk factor screening into HIV services in Swaziland: lessons from an implementation science study (2018) (20)
Can the Success of HIV Scale-Up Advance the Global Chronic NCD Agenda? (2016) (19)
Family Matters: Co-enrollment of Family Members Into Care Is Associated With Improved Outcomes for HIV-Infected Women Initiating Antiretroviral Therapy (2014) (19)
Gender Differences and Psychosocial Factors Associated with Quality of Life Among ART Initiators in Oromia, Ethiopia (2016) (19)
Gender differences in HIV-positive persons in use of cardiovascular disease-related interventions: D:A:D study (2014) (19)
Use of HIV Case Surveillance System to Design and Evaluate Site-Randomized Interventions in an HIV Prevention Study: HPTN 065 (2012) (18)
Do Thymidine Analogues, Abacavir, Didanosine and Lamivudine Contribute to the Risk of Myocardial Infarction?: The D:A:D Study (2008) (18)
Expanding access to antiretroviral therapy through the public sector--the challenge of retaining patients in long-term primary care. (2004) (18)
Achieving the 95 95 95 targets for all: A pathway to ending AIDS (2022) (17)
Help-seeking behavior of marginalized groups: a study of TB patients in Harlem, New York. (2006) (17)
Underreported injection drug use and its potential contribution to reported increase in sexual transmission of HIV in Kazakhstan and Kyrgyzstan (2019) (17)
Adherence to Pre-exposure Prophylaxis in Black Men Who Have Sex with Men and Transgender Women in a Community Setting in Harlem, NY (2020) (17)
HIV Care and Treatment Beliefs among Patients Initiating Antiretroviral Treatment (ART) in Oromia, Ethiopia (2016) (17)
Willingness to use short-term oral pre-exposure prophylaxis (PrEP) by migrant miners and female partners of migrant miners in Mozambique (2017) (16)
Clinical decision tools are needed to identify HIV-positive patients at high risk for poor outcomes after initiation of antiretroviral therapy (2017) (16)
Cardiovascular disease (CVD) and chronic kidney disease (CKD) event rates in HIV-positive persons at high predicted CVD and CKD risk: A prospective analysis of the D:A:D observational study (2017) (16)
Life in the Balance: Young Female Sex Workers in Kenya Weigh the Risks of COVID-19 and HIV (2021) (16)
A pragmatic approach to monitor and evaluate implementation and impact of differentiated ART delivery for global and national stakeholders (2018) (16)
Association Between ALT Level and the Rate of Cardio/Cerebrovascular Events in HIV-Positive Individuals: The D:A:D Study (2013) (16)
'There's no place like home': perceptions of home-based HIV testing in Lesotho. (2014) (16)
Costs of Expanded Rapid HIV Testing in Four Emergency Departments (2016) (16)
The Cost-Effectiveness of Financial Incentives for Viral Suppression: HPTN 065 Study. (2019) (16)
Increased lipoprotein remnant cholesterol levels in HIV-positive patients during antiretroviral therapy. (2008) (15)
HIV and H2O: Tracing the Connections Between Gender, Water and HIV (2013) (15)
The SAPIT trial provides essential evidence on risks and benefits of integrated and sequential treatment of HIV and tuberculosis. (2010) (15)
Clinical and laboratory correlates of human immunodeficiency virus infection in a cohort of intravenous drug users from New York, NY. (1992) (15)
Cranial epidural abscess due to Mycobacterium tuberculosis in a patient infected with the human immunodeficiency virus. (1993) (15)
“Testing, Testing”: Multiple HIV-Positive Tests among Patients Initiating Antiretroviral Therapy in Ethiopia (2017) (14)
Ending AIDS as a public health threat by 2030: Time to reset targets for 2025 (2021) (14)
Use of antiretroviral therapy by intravenous drug users with HIV. (1999) (14)
Linkage from HIV testing to care: a positive test often leads nowhere. (2013) (14)
Persistence of trophozoites after successful treatment of Pneumocystis carinii pneumonia. (1986) (14)
Abacavir use and risk of recurrent myocardial infarction (2018) (14)
Strengthening the Quality and Quantity of the Nursing and Midwifery Workforce: Report on Eight Years of the NEPI Project (2018) (14)
Covid-19, Ebola, and HIV - Leveraging Lessons to Maximize Impact. (2020) (14)
Nurse-led HIV services and quality of care at health facilities in Kenya, 2014–2016 (2017) (14)
Uptake of needle and syringe program services in the Kyrgyz Republic: Key barriers and facilitators. (2017) (13)
Ceftazidime therapy of infections caused by Enterobacteriaceae and Pseudomonas aeruginosa. (1983) (13)
Centring adolescent girls and young women in the HIV and COVID-19 responses (2020) (13)
Effects of HIV Infection on Body Composition Changes Among Men of Different Racial/Ethnic Origins (2007) (13)
The Global HIV Epidemic: What Will It Take to Get to the Finish Line? (2018) (13)
Patient-level and program-level monitoring and evaluation of differentiated service delivery for HIV: a pragmatic and parsimonious approach is needed (2017) (13)
The effects of intermittent, CD4-guided antiretroviral therapy on body composition and metabolic parameters (2010) (13)
Physician attitudes regarding bacille Calmette-Guérin vaccination and treatment of latent tuberculosis infection. (2004) (13)
HIV Prevention: Great Achievements, More Challenges Ahead (2013) (13)
Predictors of Ischemic and Hemorrhagic Strokes Among People Living With HIV: The D:A:D International Prospective Multicohort Study☆ (2019) (13)
Safer sex strategies for women: The hierarchical model in methadone treatment clinics (1999) (13)
Transitioning to Country Ownership of HIV Programs in Rwanda (2016) (13)
Re-Engineering Primary Health Care: A Formative Process Evaluation of rPHC Implementation in King Sabata Dalindyebo sub-District in the Eastern Cape Province of South Africa (2015) (12)
Health systems exist for real people. Introduction. (2009) (12)
Time to Initiation of Antiretroviral Therapy Among Patients Who Are ART Eligible in Rwanda: Improvement Over Time (2015) (12)
The Role of Financial Incentives Along the Antiretroviral Therapy Adherence Continuum: A Qualitative Sub-study of the HPTN 065 (TLC-Plus) Study (2017) (12)
Innovation to confront Ebola in Sierra Leone: the community-care-centre model. (2015) (12)
Antiretroviral Therapy for Prevention of HIV and Tuberculosis: A Promising Intervention but Not a Panacea (2013) (12)
Sexual behaviors and condom use of HIV-infected men and women of color attending a treatment and care clinic. (2005) (12)
Multiple myeloma presenting with Hemophilus influenzae septic arthritis: case report and review of the literature. (1993) (12)
Gender differences in the use of cardiovascular interventions in HIV‐positive persons; the D:A:D Study (2018) (11)
HIV‐1 seroprevalence in chest clinic and hospital tuberculosis patients in New York City, 1989–1991 (1994) (11)
Association between HIV programs and quality of maternal health inputs and processes in Kenya. (2015) (11)
Tuberculosis in Rwanda: challenges to reaching the targets (2007) (11)
Improvements over time in short-term mortality following myocardial infarction in HIV-positive individuals (2016) (11)
Health systems and health equity: The challenge of the decade (2012) (11)
Antiretroviral therapy for prevention of HIV transmission: potential role for people who inject drugs in Central Asia. (2013) (11)
Lessons from a randomised clinical trial for multidrug-resistant tuberculosis. (2012) (11)
A tale of two viruses: HIV, Ebola and health systems. (2015) (11)
Sexual Risk Behavior Among Women with Injected Drug Use Histories (1995) (11)
End of AIDS—Hype versus hope (2014) (10)
Ultrastructural markers of AIDS. (1983) (10)
Advanced Human Immunodeficiency Virus Disease at Diagnosis in Mozambique and Swaziland (2017) (10)
THE USE OF BETA‐2 MICROGLOBULIN IN THE DIAGNOSIS OF AIDS, SUSPECTED AIDS, AND PRECLINICAL AIDS a (1984) (10)
It’s all in the timing: Acceptability of a financial incentive intervention for linkage to HIV care in the HPTN 065 (TLC-Plus) study (2018) (10)
Feasibility, Acceptability, and Adherence with Short-Term HIV Preexposure Prophylaxis in Female Sexual Partners of Migrant Miners in Mozambique (2017) (10)
Neuropsychological changes in a prospectively followed cohort of intravenous drug users with and without HIV (1996) (10)
Persons living with HIV with advanced HIV disease: need for novel care models (2018) (10)
Multiple strategies to identify HIV‐positive black men who have sex with men and transgender women in New York City: a cross‐sectional analysis of recruitment results (2018) (9)
Quantitation of beta 2-microglobulin and other immune characteristics in a prospective study of men at risk for acquired immune deficiency syndrome. (1984) (9)
The PREVENT study to evaluate the effectiveness and acceptability of a community-based intervention to prevent childhood tuberculosis in Lesotho: study protocol for a cluster randomized controlled trial (2017) (9)
A time‐motion study of cardiovascular disease risk factor screening integrated into HIV clinic visits in Swaziland (2018) (9)
Expansion and scale-up of HIV care and treatment services in four countries over ten years (2020) (9)
From START to finish: implications of the START study. (2016) (9)
What one pandemic can teach us in facing another (2020) (9)
Expanding Hospital Human Immunodeficiency Virus Testing in the Bronx, New York and Washington, District of Columbia: Results From the HPTN 065 Study (2018) (9)
HIV Treatment-As-Prevention Research: Taking the Right Road at the Crossroads (2015) (9)
Use of Contemporary Protease Inhibitors and Risk of Incident Chronic Kidney Disease in Persons With Human Immunodeficiency Virus: the Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) Study (2019) (9)
The Harlem family model: a unique approach to the treatment of tuberculosis. (1995) (9)
Physician attitudes regarding latent tuberculosis infection: international vs. U.S. medical graduates. (2006) (9)
Ebola: the real lessons from HIV scale-up. (2015) (8)
Perceptions of Food-insecure HIV-positive Adults Participating in a Food Supplementation Program in Central Kenya (2014) (8)
Maternal and Infant Outcomes With Concurrent Treatment of Tuberculosis and HIV Infection in Pregnant Women (2011) (8)
A Randomized-Controlled Trial of Computer-based Prevention Counseling for HIV-Positive Persons (HPTN 065) (2017) (8)
Getting the balance right: Scaling-up treatment and prevention (2017) (8)
New Perspectives in HIV Treatment Interruption : The SMART Study (2007) (8)
Using Clinical Research Networks to Assess Severity of an Emerging Influenza Pandemic (2018) (7)
Susceptibility to levofloxacin of Myocobacterium tuberculosis isolates from patients with HIV-related tuberculosis and characterization of a strain with levofloxacin monoresistance. Community Programs for Clinical Research on AIDS 019 and the AIDS Clinical Trials Group 222 Protocol Team. (1997) (7)
Attrition From Human Immunodeficiency Virus Treatment Programs in Africa: A Longitudinal Ecological Analysis Using Data From 307 144 Patients Initiating Antiretroviral Therapy Between 2005 and 2010 (2017) (7)
Optimizing HIV prevention and treatment outcomes for persons with substance use in Central Asia: what will it take? (2019) (7)
The HIV epidemic in the United States: a time for action. Introduction. (2010) (7)
Provider attitudes about childhood tuberculosis prevention in Lesotho: a qualitative study (2019) (7)
Abacavir use and risk of recurrent myocardial infarction: the D: A: D study (2018) (7)
Predicting the short-term risk of diabetes in HIV-positive patients (2012) (7)
The acquired immune deficiency syndrome: laboratory findings, clinical features, and leading hypotheses. (1984) (6)
Examining stigma, social support, and gender differences in unsuppressed HIV viral load among participants in HPTN 065 (2020) (6)
Brief Report: Durability of the Effect of Financial Incentives on HIV Viral Load Suppression and Continuity in Care: HPTN 065 Study (2018) (6)
Tuberculosis preventive treatment preferences among care givers of children in Lesotho: a pilot study. (2018) (6)
Putting quality at the heart of HIV programs (2015) (6)
Pilot of the CoDe (Coding of Death) Project: A Standardized approach to code causes of death in HIV Infected individuals (2005) (6)
Serious clinical events in HIV-positive persons with chronic kidney disease (CKD). (2019) (6)
Lessons From Africa (2010) (6)
HIV and non-HIV – related death and their relationship to immunodeficiency (2005) (6)
Hazardous alcohol use, antiretroviral therapy receipt and viral suppression in people living with HIV who inject drugs in the U.S., India, Russia and Vietnam. (2020) (6)
Training Multidisciplinary Teams to Deliver High‐Quality HIV Care to Families in Resource‐Limited Settings: The MTCT‐Plus Initiative Experience (2012) (6)
HIV/AIDS and aging: the new frontier for HIV/AIDS research and care. (2021) (5)
Controversies in AIDS treatment. Proceedings from CME conference sponsored by Cornell University Medical College and the American Foundation for AIDS Research (AmFAR). November 8, 1997. Faculty roundtable discussion. (1998) (5)
Effects of steroid-induced Pneumocystis carinii on alveolar macrophages in the rat. (1989) (5)
Bringing HIV services to key populations and their communities in Tanzania: from pilot to scale (2021) (5)
Controversies in AIDS treatment. Proceedings from CME conference sponsored by Cornell University Medical College and the American Foundation for AIDS Research (AmFAR). November 8, 1997. Question and answer session. (1998) (5)
Risk for Non–AIDS-Defining and AIDS-Defining Cancer of Early Versus Delayed Initiation of Antiretroviral Therapy (2021) (5)
Changing Clinician Practices and Attitudes Regarding the Use of Antiretroviral Therapy for HIV Treatment and Prevention (2017) (5)
Justifying research risks in a clinical trial for treatment of multidrug-resistant tuberculosis. (2011) (5)
Public Health Implications of Adapting HIV Pre-exposure Prophylaxis Programs for Virtual Service Delivery in the Context of the COVID-19 Pandemic: Systematic Review (2022) (5)
Antiretroviral therapy recommendations for the global community: aspiration versus reality. (2014) (5)
Postprandial response to a physiologic caloric load in HIV-positive patients receiving protease inhibitor-based or nonnucleoside reverse transcriptase inhibitor-based antiretroviral therapy. (2005) (5)
Lessons From Harlem: Relevance to a Global Epidemic (2009) (5)
HIV incidence, viremia, and the national response in Eswatini: Two sequential population-based surveys (2021) (4)
Risk factors for new onset diabetes mellitus (DM) in HIV patients (2005) (4)
Associations between serum albumin and serious non-AIDS events among people living with HIV (2018) (4)
Delayed isotype switching in Dirofilaria immitis infection. (1986) (4)
Oral abstracts of the 21st International AIDS Conference 18–22 July 2016, Durban, South Africa (2016) (4)
Mycobacterium kansasii infection following primary pulmonary malignancy. (1994) (4)
HIV Care Continuum in Adults and Children: Cost-Effectiveness Considerations (2017) (4)
Rates of Tuberculosis Infection in Healthcare Workers Providing Services to HIV-Infected Populations (1998) (4)
Atazanavir (ATV)-containing Antiretroviral Treatment is not Associated with an Increased risk of Cardio- or Cerebro- Vascular Events (CVE) in the D:A:D Study (2012) (4)
LB IMPACT OF UNIVERSAL TESTING AND TREATMENT IN ZAMBIA AND SOUTH AFRICA : HPTN 071 ( POPART ) (2019) (4)
Cost-effectiveness of a combination strategy to enhance the HIV care continuum in Swaziland: Link4Health (2018) (4)
Managing early HIV infection. Agency for Health Care Policy and Research. (1994) (4)
Annotation: wanted--a simple and meaningful HIV staging system. (1997) (4)
Oral abstracts of the 21st International AIDS Conference 18–22 July 2016, Durban, South Africa (2016) (4)
The science of Durban, AIDS 2016 (2017) (4)
Changes in D-dimer after initiation of antiretroviral therapy in adults living with HIV in Kenya (2020) (4)
Model-Based Predictions of HIV Incidence Among African Women Using HIV Risk Behaviors and Community-Level Data on Male HIV Prevalence and Viral Suppression. (2020) (4)
Improving child tuberculosis contact identification and screening in Lesotho: Results from a mixed-methods cluster-randomized implementation science study (2021) (4)
El Manual Clínico Pediátrico (2004) (3)
The pediatric clinical manual the International Center for AIDS Programs. (2004) (3)
Exposure to antiretroviral therapy and the risk of liver-related death: Is there an association? Results from the D :A :D study group (2006) (3)
Sex Differences in Mortality and Loss Among 21,461 Older Adults on Antiretroviral Therapy in Sub-Saharan Africa. (2016) (3)
Factors Associated with Use of Short‐Term Pre‐Exposure Prophylaxis for HIV Among Female Partners of Migrant Miners in Mozambique (2017) (3)
Model-based predictions of HIV incidence among African women using HIV risk behaviors and community-level data on male HIV prevalence and viral suppression. (2020) (3)
Difference in clinical implications of CD4 counts among HIV-infected homosexual men and injection drug using men and women. (1995) (3)
Cessation of cigarette smoking and the impact on cancer incidence in HIV-positive persons : The D : A : D Study (2018) (3)
Echoing the Lessons of HIV: How to Serve the Millions with Cardiovascular Disease (2014) (3)
Group C streptococcal subdural empyema in a healthy man: possible complication of pharyngitis. (1993) (3)
Assessing the Information-Motivation-Behavioral Skills Model to Predict Pre-exposure Prophylaxis Adherence Among Black Men Who have Sex with Men and Transgender Women in a Community Setting in New York City (2022) (3)
Ebola: the real lessons from HIV scale-up. (2015) (3)
Impact of Antiretroviral Drugs on Hypertension in HIV-positive Persons: D:A:D Study (2015) (3)
The Metabolic Syndrome at baseline in the D:A:D study (2006) (3)
Use of Index Patients to Enable Home-Based Testing in Lesotho (2017) (3)
Liver-related deaths among HIV-infected persons: Data from the D:A:D study (2005) (3)
Leveraging differentiated HIV service delivery to expand tuberculosis preventive treatment: a call to action. (2020) (3)
Non-AIDS defining malignancies (NADM) and immunosuppression: The D:A:D study (2012) (3)
Exploring individual-level barriers to HIV medication adherence among men who have sex with men in the HIV Prevention Trials Network (HPTN 065) study (2020) (3)
Challenges and Opportunities in China’s Health Aid to Africa: Findings from Qualitative Interviews in Tanzania and Malawi (2020) (3)
Pneumocystis carinii infections in patients with AIDS. (1987) (3)
Sexually transmitted infections in women infected with the human immunodeficiency virus. Terry Beirn Community Programs for Clinical Research on AIDS (CPCRA). (1998) (3)
Rationale and design of a study using a standardized locally procured macronutrient supplement as adjunctive therapy to HIV treatment in Kenya (2013) (3)
Lipid profiles in HIV-1-infected individuals receiving combination antiretroviral therapy: are different protease inhibitors or non-nucleoside reverse transcriptase inhibitors associated with different lipid profiles? (2004) (2)
The impact of immunosuppression on chronic kidney disease in people living with HIV; the D:A:D study. (2020) (2)
Does directly observed therapy work? (1999) (2)
Paediatric tuberculosis preventive treatment preferences among HIV-positive children, caregivers and healthcare providers in Eswatini: a discrete choice experiment (2021) (2)
World Health Organization Public Health Approaches to Expand Antiretroviral Treatment Public Health Approaches to Expand Antiretroviral Treatment (2003) (2)
Association between dideoxynucleoside analogues (d-Drugs) and end-stage liver disease (ESLD) (2014) (2)
Relationship between prolonged exposure to combination antiretroviral therapy and myocardial infarction: effect of sexe, ange and lipid changes (2005) (2)
Candida albicans infection of an arteriovenous graft used for hemodialysis. (1987) (2)
Effects of Different Interventions to Improve ART-associated Dyslipidemia (2006) (2)
Some thoughts on the acquired immunodeficiency sydrome (AIDS) (1985) (2)
Low rates of prior HIV testing among HIV-positive adults accessing outpatient services in Eswatini (2019) (2)
“What will we do if we get infected?”: An interview-based study of the COVID-19 pandemic and its effects on the health and safety of sex workers in the United States (2021) (2)
87 – The Effect of Gender on the Epidemiology, Clinical Presentation, and Management of Tuberculosis (2004) (2)
Rates of viral suppression in a cohort of people with stable HIV from two community models of ART delivery versus facility-based HIV care in Lusaka, Zambia: a cluster-randomised, non-inferiority trial nested in the HPTN 071 (PopART) trial (2021) (2)
From guidelines to action: implementation opportunities and realities (2014) (2)
Cost‐effectiveness of statins for primary prevention of atherosclerotic cardiovascular disease among people living with HIV in the United States (2021) (2)
Healthcare system responses to non-communicable diseases’ needs of Syrian refugees: The cases of Jordan and Lebanon (2022) (2)
Use of contemporary protease inhibitors and risk of incident chronic kidney disease in HIV-positive persons; the D:A:D Study. (2019) (2)
Association of sociodemographic factors with needle sharing and number of sex partners among people who inject drugs in Egypt (2021) (2)
Integrating tuberculosis and HIV care in rural Rwanda. (2008) (2)
Relationship between use of stavudine and diabetes mellitus (2006) (2)
Use of awareness raising campaigns to expand HIV testing: experiences in the Bronx, NY and Washington, DC (HPTN 065 study) (2020) (2)
Collaborators Interruption of antiretroviral therapy is associated with increased plasma cystatin (2009) (2)
Managing early HIV infection (1994) (2)
Presence of the Metabolic Syndrome Is Not a Better Predictor of Cardiovascular Disease than the Sum of its Components: Data from the D:A:D Study (2007) (2)
IMMUNOLOGIC ABNORMALITIES AMONG MALE HOMOSEXUALS IN NEW YORK CITY: CHANGES OVER TIME a (1984) (1)
A Chronicle of Hope and Promise: The World As It Was, As It Is, and As It Can Be (2012) (1)
Effect of HIV Infection on Response to Syphilis (1993) (1)
Fostering the nursing/midwifery workforce in sub-Saharan Africa (2014) (1)
Culture-Negative Tuberculosis in an Inner City Hospita (2003) (1)
COVID-19 Mitigation Efforts and Testing During an In-Person Training Event — Uganda, October 12–29, 2020 (2021) (1)
From HIV to global health: opportunities and challenges (2012) (1)
Tuberculosis Screening and Diagnosis in People with HIV (2010) (1)
HPTN 069/ACTG A5305: phase II study of maraviroc-containing regimens for HIV PrEP in US women; Postive impact of a randomized controlled trial of the Uthando Lwethu ("Our Love") intervention on rates of couples HIV testing in rural South Africa (2016) (1)
The Global HIV Epidemic: Perfect Storm, Silver Lining (2006) (1)
Clinical trials provide the evidence critical for patient empowerment (2013) (1)
A public health approach to addressing and preventing misdiagnosis in the scale‐up of HIV rapid testing programmes (2017) (1)
Beyond the Magic Bullet: What Will It Take to End the AIDS Epidemic? (2021) (1)
High prevalence of pre-diabetes among people living with HIV in a high TB burden setting. (2020) (1)
Track C Epidemiology and Prevention Science (2012) (1)
Projected outcomes of universal testing and treatment in a generalised HIV epidemic in Zambia and South Africa (the HPTN 071 [PopART] trial): a modelling study (2022) (1)
Bridging the divide. (2011) (1)
Individual and poly-substance use and condomless sex among HIV-uninfected adults reporting heterosexual sex in a multi-site cohort (2020) (1)
P09 A data collection system designed to facilitate participation in multiple concurrent clinical trials (1995) (1)
Predictors of advanced chronic kidney diseases and end-stage renal diseases in HIV- positive persons in D:A:D (2013) (1)
The Looming Threat: Cancer in Sub‐Saharan Africa (2021) (1)
Does diabetes mellitus (DM) confer an equivalent risk of coronary heart disease (CHD) to pre-existing CHD in HIV-positive individuals? (2007) (1)
Group Associations between markers of Immunosuppression and the risk of cardiovascular disease (CVD): the D:A:D study (2012) (1)
Comorbidity of Human Immunodeficiency Virus Infection and Disseminated Tuberculosis in Patients at Harlem Hospital Center (2003) (0)
Review of the pilot of a new data collection system to investigate causes of death in HIV: the CoDe (coding of Death) project (2005) (0)
Tuberculosis and HIV-needed: a new paradigm for the control and management of linked epidemics. (2007) (0)
Hypertension in HIV-infected patients (2005) (0)
SAFEK SEX STKATEGIES FOK WOMEN. THE HIEKAKCHICAL MODEL IN METHADONE TKEATMENT CLINICS (1999) (0)
System Failure versus Personal Accountability — The Case for Clean Hands (2006) (0)
A Decade of Training in Global Public Health: Achievements and Lessons Learned (2020) (0)
Meet the Professors (2004) (0)
Stemming the U.S. HIV epidemic: act local. (2012) (0)
Abstract 680: Antiretroviral Therapy in HIV-Positive Patients Results in a Pro-Atherogenic Postprandial Pattern with Increased Lipoprotein Remnant Cholesterol Levels (2006) (0)
Eleventh International Congress on Drug Therapy in HIV Infection (2012) (0)
Changes in lipid levels in individuals receiving combination antiretroviral therapy and their relationship to risk of myocardial infection (2005) (0)
PP-149 Patient centered peer based program to improve adherence to HIV therapy. The HATS-PC initiative (2009) (0)
Hypertension in HIV-infected patients (vol 10, pg 811, 2005) (2005) (0)
Antiretroviral Challenges in the Global Setting (2008) (0)
The Potential for channelling bias when investigating the associations between specific NRTI drugs and the occurence of adverse events (2008) (0)
310-PA12 The need for unique directly observed therapy (DOT) programs targeting TB patients (PTS) in inner cities in developed countries (1995) (0)
Photo quiz. Aberrant fat deposition (benign lipomatosis) in association with highly active antiretroviral therapy. (1999) (0)
Improvements over time in short-term mortality following myocardial infarction in the D: A: D Study (2016) (0)
Consumption Rate of a Whole‐Food Macronutient Supplement for Adults Initiating Antiretroviral Therapy in Kenya (2013) (0)
Policy and Human Rights Implications of Women’s Poverty and Vulnerability in the USA (2017) (0)
Effectiveness of a community-based intervention to prevent childhood TB in Lesotho. (2022) (0)
Prevalence of neurotoxicity symptoms among postpartum women on isoniazid preventive therapy and efavirenz-based treatment for HIV: an exploratory objective of the IMPAACT P1078 randomized trial (2023) (0)
Integrated vs. referred management of CVD risk factors for HIV positive patients on antiretroviral therapy in Swaziland (2018) (0)
Assessment of the impact of early ART on sexual behaviour in INSIGHT strategic timing of antiretroviral treatment (START) trial (2016) (0)
O314 Predicting the short-term risk of diabetes in HIV-infected patients in the D:A:D cohort: the D:A:D study group (2008) (0)
Innovations, adaptations, and accelerations in the delivery of HIV services during COVID-19 (2022) (0)
Clinicians' discussion: trends in HIV care. (2000) (0)
Matching their courage. Care. (1998) (0)
Hype versus hope − − End of AIDS (2014) (0)
Question-and-Answer Session (2010) (0)
Relationship of postprandial nonesterified fatty acids, adipokines, and insulin across gender in human immunodeficiency virus-positive patients undergoing highly active antiretroviral therapy. (2009) (0)
Is diabetes mellitus (DM) a coronary heat disease (CHD) risk equivalent in HIV-positive individuals?: The D:A:D Study (2008) (0)
The Impad of Human Immunodeficiency Virus Infedion on Drug-resistant Tuberculosis (1996) (0)
Cardiovascular events (CVE) in the DAD Study (2004) (0)
Concerns over cardiovascular disease: Trends in ART discontinuation and the introduction of lipid lowering drugs over the period 1999-2004 (2005) (0)
Ascertainment and classification of strokes in HIV infected individuals, The DAD Study (2004) (0)
Investigating the Causal Impact of PI- and NNRTI-containing Combination Antiretroviral Therapy (cART) on the Risk of Mortality: Methodological Challenges (2013) (0)
In Memoriam, Fred Gordin, MD, 1951-2018. (2018) (0)
The HIV response and global health (2019) (0)
Cancers or not?: Collection and preliminary assessment of non-AIDS-defining malignancies (NADMs) in the D:A:D Study (2011) (0)
Engaging to end the epidemic: seven essential steps toward an AIDS-free generation. (2012) (0)
AssociationBetweenHIV ProgramsandQualityof MaternalHealthInputs andProcessesinKenya (2015) (0)
When to start ART in Africa. (2013) (0)
International Congress of Drug Therapy in HIV Infection 2‐6 November 2014, Glasgow, UK (2014) (0)
’ s response to reviews Title : Is there continued evidence for an association between abacavir usage and myocardial infarction risk in individuals with human immunodeficiency virus ( HIV ) ? : a cohort collaboration (2016) (0)
HTLV-III seropositivity and its relationship to disease in a prospective study of homosexual males [abstract] (1985) (0)
The Impact of missing data on the association between antiretroviral use and myocardial infarction (2009) (0)
Power and the female condom. The authors reply [letter] (1996) (0)
International Congress of Drug Therapy in HIV Infection 2‐6 November 2014, Glasgow, UK (2014) (0)
OL-042 Asymptomatic bacterial STD screening: experience from an inner city HIV clinic (2009) (0)
Tuberculosis Knowledge, Attitudes and Beliefs Scale (2013) (0)
Uncontrolled Hypertension amongst People Living with HIV on Antiretroviral Therapy at an Urban HIV Clinic in Swaziland (2017) (0)
Fasting and Nonfasting Triglycerides and Risk of Myocardial Infarction in HIV-infected Persons: The D:A:D Study (2009) (0)
Predicting the short term risk of diabetes in HIV infected patients The D:A:D study group (2008) (0)
Correlation of bronchoalveolar lavage bal cell populations with clinical severity of pneumocystis carinii pneumonia pcp (1987) (0)
Early initiation of antiretroviral therapy: debate over? - Authors' reply. (2016) (0)
Double Scourge : Tuberculosis and HIV Coinfection (2001) (0)
Faculty Roundtable Discussion (1998) (0)
No Need for Apologies (2011) (0)
Cardiovascular outcomes in HIV Infections (2005) (0)
PL07.1 Global trends in HIV in the era of combination prevention – what progress have we made towards elimination? (2019) (0)
Risk Factors for new onsed diabetes mellitus in HIV patients (2005) (0)
Correction to: China’s health assistance to Africa: opportunism or altruism? (2018) (0)
The Metabolic Syndrome in the D:A:D study (2006) (0)
Answer to photo quiz (see page 239) (1999) (0)
Ultrastructural changes in HIV infection. (1987) (0)
Evaluation of sudden death and non-haemorrhagic stroke and their association with HIV protease inhibitor (PI) usage (2010) (0)

This paper list is powered by the following services:

Other Resources About Wafaa El-Sadr

What Schools Are Affiliated With Wafaa El-Sadr?

Wafaa El-Sadr is affiliated with the following schools:

Wafaa El-Sadr's Academic­Influence.com Rankings

Wafaa El-Sadr's Degrees

Why Is Wafaa El-Sadr Influential?

Wafaa El-Sadr's Published Works

Published Works

Other Resources About Wafaa El-Sadr

What Schools Are Affiliated With Wafaa El-Sadr?

Image Attributions

Wafaa El-Sadr's AcademicInfluence.com Rankings